Although stability of NRF2 can be regulated by diverse post-translational modifications such as phosphorylations by various upstream kinases10, currently there is no direct link between NRF2 and HER2 in the regulation of drug resistance of cancer cells. The gene discussed is ERBB2; the disease is cancer.